Assisted yes, but where do we draw the line?

Treating prostate cancer: where do we draw the line?

The article by Drs. Lepor and Donin is a provocative look at a timely topic in urologic oncology.[1] There is little debate among experts in the field that we are overtreating prostate cancer at the current time. Studies are ongoing to evaluate active surveillance as an option for low-risk tumors, even in men with very long life expectancies. However, in this review, the authors have overreache...

Where do you draw the line?

Yes we can, but do we?

In recent decades, a curious demographic phenomenon has emerged in US science. A high and increasing proportion of PhD students and postdocs, especially in the life sciences, are drawn from beyond the shores of North America. The reasons for this are undoubtedly complex. One factor is the widespread perception in the USA that a career in academic science is marked by low salaries, poor job secu...

Procedural sedation in the emergency department: where do we draw the line?

Mary Jagim is Consultant, Senior Health Care Analyst, E Suite Consulting, Fargo, ND. For correspondence, write: Mary Jagim, RN, BSN, CEN, FAEN, 6030 23rd Street South, Fargo, ND 58104; E-mail: [email protected]. J Emerg Nurs 2007;33:488-91. 0099-1767/$32.00 Copyright n 2007 by the Emergency Nurses Association. doi: 10.1016/j.jen.2007.06.012 A male patient presents to triage in severe pain an...

Replacement of the ascending aorta in bicuspid aortic valve disease: where do we draw the line?